| 2023-06-16 | Zymeworks Inc. ZYME | 10 percent owner | 3.35M 5.0195% | $8.12 | $27.2M | +7.27% | ||
| 2023-03-28 | Zymeworks Inc. ZYME | 10 percent owner | 200,000 0.2981% | $8.00 | $1.6M | +6.44% | ||
| 2023-01-20 | Zymeworks Inc. ZYME | director | 163,400 0.2428% | $9.88 | $1.62M | -16.45% | ||
| 2023-01-19 | Zymeworks Inc. ZYME | director | 144,100 0.2124% | $9.49 | $1.37M | -13.66% | ||
| 2023-01-18 | Zymeworks Inc. ZYME | director | 203,000 0.3051% | $10.00 | $2.03M | -16.43% | ||
| 2023-01-17 | Zymeworks Inc. ZYME | director | 440,000 0.6486% | $9.80 | $4.31M | -16.43% | ||
| 2023-01-13 | Zymeworks Inc. ZYME | director | 342,100 0.5024% | $9.81 | $3.35M | -16.78% | ||
| 2023-01-11 | Sale | Voyager Therapeutics, Inc. VYGR | director | 110,000 0.2722% | $8.50 | $934,615 | -9.72% | |
| 2023-01-11 | Zymeworks Inc. ZYME | director | 106,300 0.1527% | $7.87 | $836,911 | +1.43% | ||
| 2023-01-10 | Sale | Voyager Therapeutics, Inc. VYGR | director | 336,400 0.8885% | $8.05 | $2.71M | +1.82% | |
| 2023-01-10 | Zymeworks Inc. ZYME | director | 920,000 1.3565% | $7.65 | $7.04M | +7.02% | ||
| 2023-01-09 | Sale | Voyager Therapeutics, Inc. VYGR | director | 456,000 1.3029% | $7.67 | $3.5M | +15.43% | |
| 2022-06-21 | Voyager Therapeutics, Inc. VYGR | 376,000 1.0477% | $5.66 | $2.13M | +28.87% | |||
| 2022-05-05 | Sale | Prothena Corporation plc PRTA | 1.06M 2.2706% | $29.02 | $30.84M | +77.02% | ||
| 2022-05-05 | Prothena Corporation plc PRTA | 1.06M 2.2706% | $29.02 | $30.84M | +77.02% | |||
| 2022-01-12 | Prothena Corporation plc PRTA | 10 percent owner | 300,000 0.6429% | $37.50 | $11.25M | -9.98% | ||
| 2021-10-01 | Sale | Corvus Pharmaceuticals, Inc. CRVS | 10 percent owner | 2M 4.4342% | $4.96 | $9.93M | -67.36% | |
| 2021-09-30 | Sale | Corvus Pharmaceuticals, Inc. CRVS | 10 percent owner | 3M 6.7156% | $5.04 | $15.13M | -67.46% | |
| 2021-05-04 | AnaptysBio, Inc. ANAB | 165,000 0.5959% | $23.25 | $3.84M | +12.89% | |||
| 2021-05-03 | AnaptysBio, Inc. ANAB | 20,800 0.0748% | $23.31 | $484,873 | +12.04% |